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Abstract
!
The unsaponifiable fraction of olive oil from un-
ripe fruits of Olea europaea at different stages of
maturation (from 20 to 32 weeks after flowering)
was analyzed by gas chromatography-mass spec-
trometry in order to select the time associated to
the unsaponifiable fraction with the maximal
yield in bioactive constituents. According to
quantitative gas chromatography-mass spec-
trometry analysis, the unsaponifiable fraction
(2.46% of the total oil) from olive fruits at the
22nd week was found to contain the maximal
yield in anti-inflammatory constituents. Its com-
position was lanosterol (2.60mg/g oil), stigmas-
terol (2.15), cycloartanol acetate (2.04), stigma-
stan-3,5-diene (2.01), obtusifoliol (1.93), choles-
ta-4,6-dien-3-one (1.42), α-amyrin (1.42), α-toco-
pherol (1.32), squalene (1.02), β-amyrin (0.57),
and β-sitosterol (0.22). At later times, there was a
decrease in the quantitative unsaponifiable frac-
tion yield and a qualitative shift in the bioactive
constituents. The 22nd week unsaponifiable frac-
tion was subsequently incorporated into a topical
preparation to be utilized for a small pilot clinical
study in five patients affected by osteoarthrosis.
According to clinical observation, the application
of the ointment (three times daily for three
weeks) attenuated hand and knee joint inflam-
matory features in all patients andwas not associ-
ated to any adverse reactions.
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Olive oil is a functional food from Olea europaea L.
(Oleaceae), which, in quantitative terms, can be
classified into two fractions: the major one, com-
posed of tryglycerol compounds (TAGs, 97–98%),
of which 60–85% are esterified with monounsat-
urated fatty acids (MUFA), and the remainding
one, accounting for 3–21%, containing poly-
unsaturated fatty acids (PUFA). The second frac-
tion comprises minor components of virgin olive
oil (1–2%) made up of the unsaponifiable fraction
(UF), whose molecular structures are extractable
by the solvent after saponification of the oil (hy-
drocarbons, tocopherols, fatty alcohol, triterpenic
derivatives, phytosterols, etc.).
It is widely believed that the anti-inflammatory
minor components of the UF concur with phe-
nolics in the oil matrix (tyrosol, hydroxytyrosol,
oleorupein, gallic, cumaric, and caffeic acids) in
preventing the onset and propagation of inflam-
matory processes at different sites, including the
vascular endothelium, whose dysfunction leads
to cardiovascular disease in humans. However,Gelmini F et al.the qualitative and quantitative composition of
bioactive constituents of olive fruits, including
those present in the UF, appears quite variable
during their development and may depend upon
the specific stage of maturation [1], thus resulting
in a variable anti-inflammatory activity. In con-
sideration of such composition variability, the
first aim of the study was to isolate and qualita-
tively characterize the UFs present in the oil sam-
ples obtained from drupes harvested at different
stages (20–32 weeks after flowering; WAF) of
maturation. The aimwas to define the period that
would give an oil containing a UF with the highest
yield of anti-inflammatory constituents (sterols,
triterpenoids, squalene, etc.). The second aim of
the study was to quantitatively define the constit-
uents of the UF isolated from the oil of the period
of interest.
This olive oil fraction has never been evaluated for
the treatment of chronic inflammatory disorders
such as osteoarthritis (OA), which shares several
inflammatory and immunological pathways with
cardiovascular disease [2]. The phytotherapeutic
approach with herbal medicinal products for theUnsaponifiable Fraction of… Planta Med 2016; 82: 273–278
Table 1 Qualitative and semi-quantitative GC‑MS analysis of the UFs at the
22, 25, 32 WAF.
Relative percentage (%)
Unsaponifiable compound 22 WAF 25 WAF 32 WAF
Squalene 29.46 63.72 79.32
β-Sitosterol 15.35 14.25 10.83
α-Amyrin 12.74 n.d. n.d.
α-Tocopherol 12.24 8.82 2.67
β-Amyrin 6.26 n.d. n.d.
Lanosterol 4.49 2.55 3.27
Stigmasterol 3.28 2.86 2.73
Cycloartanol acetate 2.99 n.d. n.d.
Stigmastan-3,5-diene 2.93 n.d. n.d.
Obtusifoliol 2.71 n.d. n.d.
Cholesta-4,6-dien-3-one 1.66 n.d. n.d.
9,19-Ciclolanost-7-en-3-ol 1.41 n.d. n.d.
Cholest-4-en-3-one 1.37 n.d. n.d.
minor compounds (< 2%) 3.11 7.8 1.18
Individual data are expressed as relative % (calculated from the area under each peak)
of the total pool area; n = 3; S.D. < 10%; n.d., not detectedFig. 1 Quantitative profile (% content w/w) of the UFs from unripe fruits
at different stages of maturation. Time is reported as weeks after flowering

































l.management of OA is still in its infancy. In any case, complemen-
tary and alternative medicine has been proposed as a substitute
and/or a complement to conventional therapies [3]. Dietary sup-
plements containing ω-3 fatty acids achieve worthwhile im-
provement and phytoextracts containing boswellic acid, curcu-
min, devilʼs claw, capsaicin, andrographolide [from Andrographis
paniculata (Burm.f.) Wall. ex Nees (Acanthaceae)] as such or as
herbal mixtures have given promising results for OA treatment,
with no adverse reactions [4]. In light of these observations and
of recent in vitro and in vivo data demonstrating the anti-inflam-
matory efficacy of the UFs from some other oils, such as Awara
pulp from Astrocaryum vulgareM. (Arecaceae) [5], Oenothera bi-
ennis L. (Onagraceae) [6], and Cucurbita maxima Duchesne (Cu-
curbitaceae) [7], the present research project also included a
small pilot study designed to investigate whether the anti-in-
flammatory constituents of the UF of olive oil, after suitable for-
mulation in an ointment, may relief of joint inflammatory symp-
toms in a small group of OA patients.Results
!
The quantitative profile of the yield of the UFs from the oils from
unripe fruits harvested at different stages of maturation from 20
to 32 WAF is shown inl" Fig. 1. Compared to extra virgin oil from
mature fruits, containing about 0.5% UF, the oil from unripe fruits
showed a greater UF content already at 20 WAF (about a 3-fold
increase), with a further increase at subsequent times, peaking
at 22 WAF [a 5-fold increase, corresponding to 2.46% of the total
oil (w/w)]. The UF content decreased thereafter, progressively
falling to 0.88% of the total oil when the olives were nearly ripe
(32 WAF).
The qualitative pattern of the UF constituents at different matu-
ration periods (22, 25, and 32WAF) was determined by gas chro-
matography-mass spectrometry (GC‑MS) analysis (l" Table 1), al-
lowing the detection of squalene, β-sitosterol, α-tocopherol, lan-
osterol, and stigmasterol at all WAF tested. However, α-amyrin,Gelmini F et al. Unsaponifiable Fraction of… Planta Med 2016; 82: 273–278β-amyrin, stigmastan-3,5-diene, obtusifoliol, cycloartanol ace-
tate, cholesta-4,6-dien-3-one, 9,19-ciclolanost-7-en-3-ol, and
cholest-4-en-3-one were detected only at 22 WAF, and not at 25
and 32 WAF, indicating consistent changes in bioactive constitu-
ents over the time of development. Interestingly, most of the con-
stituents detected at 22 WAF have been proposed as early bio-
synthetic intermediates of the sterol pathway [8]. This analysis
also gave semiquantitative indications on the relative percentage
of each component (l" Table 1). For the quantitative analysis
(l" Table 2) of each UF constituent at the 22, 25, and 32 WAF, a
calibration curve was set. Among the compounds detectable at
all time points, at 22 WAF, lanosterol was 2.60mg/g oil and stig-
masterol was 2.15mg/g oil and both decreased to about 1mg/g
oil at 25 and 32 WAF. Moreover, squalene was 1.02mg/g oil at
22WAF, increased to 2.22mg/g oil at 25WAF and then decreased
to 1.38mg/g oil at 32WAF; β-sitosterol was 0.22mg/g oil and de-
creased to about 0.13mg/g oil at 25 and 32 WAF; and α-toco-
pherol was 1.32mg/g oil and decreased to about 0.40mg/g oil at
25 and 32WAF. The drop in α-tocopherol paralleled the decrease
in the UF content of the oils from drupes at different harvesting
times. This suggests that this antioxidant has some sort of protec-
tive action on the constituents of the unsaponifiable matter. In
line with the qualitative data, we could detect α-amyrin, β-amyr-
in, stigmastan-3,5-diene, obtusifoliol, cycloartanol acetate, and
cholesta-4,6-dien-3-one only at 22 WAF, and not at 25 and 32
WAF.
The main physicochemical characteristics of oil from unripe
olives (22 WAF) have also been evaluated [free acidity value ex-
pressed as oleic acid (1.043), low peroxide index (7.032), saponi-
fication value (184.46), and iodine value (76.329)], suggesting
that it may be classified as extra virgin oil according to Eu.Ph. 7.0.
To sum up, the UF from unripe oil (22 WAF) contains a bulk of
molecules with potential pharmacological activity (anti-inflam-
matory, antioxidant) and, most important, present in a consistent
amount.
The results of the pilot study on the efficacy of the ointment con-
taining 5% of the bioactive UF (22 WAF) in the relief of active OA
signs and symptoms are reported in l" Table 3. The application
(three times/day for three weeks) of the UF ointment resulted in
a significant overall improvement of the clinical features in all OA
Table 2 Quantitative GC‑MS
analysis of the UF constituents at
the 22, 25 and 32 WAF.
Quantitative analysis (mg/goil)
22 WAF 25 WAF 32 WAF
Unsaponifiable compound mean ± SD mean ± SD mean ± SD
Lanosterol 2.60 0.12 1.02 0.08 0.97 0.07
Stigmasterol 2.15 0.17 1.04 0.09 0.96 0.05
Cycloartanol acetate 2.04 0.09 n.d. n.d. n.d. n.d.
Stigmastan-3–5-diene 2.01 0.06 n.d. n.d. n.d. n.d.
Obtusifoliol 1.93 0.06 n.d. n.d. n.d. n.d.
Cholesta-4,6-dien-3-one 1.42 0.03 n.d. n.d. n.d. n.d.
α-Amyrin 1.42 0.04 n.d. n.d. n.d. n.d.
α-Tocopherol 1.32 0.07 0.47 0.03 0.40 0,00
Squalene 1.02 0.02 2.22 0.02 1.38 0.01
β-Amyrin 0.57 0.01 n.d. n.d. n.d. n.d.
β-Sitosterol 0.22 0.01 0.14 0.02 0.13 0.02
(n = 3; n.d., not detected)
Table 3 Clinical effect of 5% bioactive UF (22 WAF) ointment on hand and
knee osteoarthrosis symptoms and signs.
Time (week) VAS evaluation p
Pain 0 8.0 ± 0.2 –
1 5.2 ± 1.1 0.028








l.patients after two and three weeks of treatment. In particular,
joint pain, as evaluated by the visual analogue scale, was reduced
from 8.0 to 2.2 (p = 0.02 at three weeks). In addition, joint red-
ness, heat, edema, and loss of mobility were also significantly im-
proved. As expected, joint deformity was not affected at any time
point. All subjects completed the study and experienced no ad-
verse reactions.3 2.2 ± 1.1 0.002
Redness 0 3.0 ± 0.2 –
1 2.4 ± 0.6 0.423
2 1.6 ± 0.6 0.028
3 1.2 ± 0.8 0.050
Heat 0 2.8 ± 0.4 –
1 2.0 ± 0.7 0.097
2 1.2 ± 0.4 0.017
3 0.8 ± 0.4 0.001
Oedema 0 3.0 ± 0.2 –
1 2.0 ± 0.2 0.005
2 1.4 ± 0.5 0.017
3 0.6 ± 0.5 0.004
Loss of mobility 0 3.4 ± 0.5 –
1 2.2 ± 0.5 0.023
2 1.8 ± 0.8 0.017
3 1.0 ± 0.7 0.004
Joint deformity 0 1.4 ± 0.5 n. s.
1 1.4 ± 0.5 n. s.
2 1.4 ± 0.5 n. s.
3 1.4 ± 0.5 n. s.



























This study evaluated the qualitative and quantitative composi-
tion of the UF present in the oil of unripe olives. The analytical
data allowed us to depict very relevant variations in the phyto-
chemical profile of the bioactive structures across drupe ontol-
ogy, since the UF amount was greater at 22 WAF and decreased
during fruit maturation. The main constituents of the 22 WAF
UF are triterpenes with anti-inflammatory properties. Thus, a de-
tailed analytical investigation by GC‑MS allowed us to identify
the period (22 WAF) at which the oil obtained from drupes gives
the major yield in anti-inflammatory UF constituents and
showed us a picture of the different steps on the biosynthetic re-
lationship between steroid and triterpenoid pathways through-
out O. europaea fruit development. In contrast to what was ob-
served by Sakouhi et al. [8], who worked on Meski olives and de-
picted a decline in squalene content between 21 and 26WAF, we
still observed a strong accumulation of squalene at 32WAF (near
the final time of maturation), which may be due to different fac-
tors, including environmental and climatic conditions, that may
influence the kinetics of fruit development and the fruit cultivar.
According to these observations, a detailed control of the compo-
sition of the bioactive constituents of unripe fruits, before the
evaluation of their biological activities, appears mandatory.
Moreover, we found the presence of elevated amounts of α- and
β-amyrins until 22 WAF. Afterwards, there is a redirection of the
carbon flux from the triterpenoid pathway to the steroid path-
way, with elevated lanosterol and stigmasterol content at 22
WAF and a peak in squalene production at 25WAF, in accordance
with the findings of Stiti et al. [9].
The concept that oil from unripe olives possessesmedicinal prop-
erties actually dates back to antiquity. The Romans called this oil
OleumOmphacium, and Dioscorides (ca. 40–90 AD) and Pliny the
Elder (23–79 AD) mentioned that it was used as a vehicle for pre-
serving perfumes and as a beneficial health food [10]. The poten-
tial anti-inflammatory activity of the UF frommature virgin oliveoil has previously been reported by Rocho de la Puerta et al. [11]
in a study of mice, showing the anti-inflammatory action of the
UF after topical application of the active material (0.5mg/ear) on
auricular edema. In agreement with these observations, the re-
sults of the pilot study in OA patients indicate that the UF from
the oil of unripe olives strongly attenuates the severity of active
OA signs and symptoms when topically applied to inflamed
joints. The ointment was designed to contain a high concentra-
tion of UF bioactive constituents, and the vehicle, due to the pres-
ence of essential oils and grade B shea butter, which are devoid of
any biological activity, is, however, a strong enhancer of skin pen-
etration of these bioactives. From a mechanistic viewpoint, the
beneficial effects of the UF on OAmay stem from an overall inhib-
itory action on well-distinct triggers of the inflammatory cas-
cade. In particular: 1) phytosterols, such as β-sitosterol, which
exert a strong anti-inflammatory action by inhibiting nuclearGelmini F et al. Unsaponifiable Fraction of… Planta Med 2016; 82: 273–278
276 Original Papersfactor-kB nuclear translocation [11], and interleukin-6 and tu-
mor necrosis factor-α secretion [12,13]; 2) α-β amyrins, with
both antinociceptive and anti-inflammatory activity [14,15]; 3)
α-tocopherol, which prevents the increase in prostaglandin E2
and thromboxane 2 in LPS-stimulated macrophages, partly
through inhibition of cyclooxygenase and lipooxygenase transla-
tion and partly by directly scavenging free radicals •OH and NO•
[16]; and 4) squalene is endowed with a strong scavenging activ-
ity [17] against superoxide anion and its metabolites. These pre-
liminary clinical data in OA patients clearly need to be confirmed
and validated by larger clinical trials with an appropriate design.
Moreover, besides the efficacy of UF from the oil of unripe olives
in attenuating OA symptoms, this oil, as such, may also be taken
into consideration for the development of nutraceuticals for the
prevention and treatment of other chronic diseases where the

































Plant material and analytical protocol
The experiment took place during 2011 (pilot experiment) and
was completed in 2012. Unripe drupes from the cultivar “Gen-
tile” were hand-harvested weekly from the 20 WAF until com-
plete maturity of the fruits (32 WAF). Olives without physical
damage were selected from multiple trees of the same cultivar
and prepared for the extraction step. Samples of olive fruits
(300 ± 10 g) at different stages of development were ground using
a laboratory scale hammer mill and the material quantitatively
recovered was extracted with n-hexane using a Soxhlet appara-
tus (90min). The procedure was repeated three times and the or-
ganic extracts were collected, filtered on anhydrous sodium sul-
phate, and taken to dryness under reduced pressure at 20°C to
give the oil fractions. These fractions were submitted to the sap-
onification procedure [18] and the isolated UFs (gravimetrically
determined), were quali/quantitatively analyzed by GC‑MS [19].
Having established which stage of olive fruit maturation would
give a UF containing the greatest amount of bioactive constitu-
ents, in the next year (2012) the drupes at the same stage of mat-
uration were submitted to a conventional cold press method and
the oil recovered was used, in part, for UF isolation after an ana-
lytical control of its composition and, in part, to check the physi-
cochemical parameters routinely employed to define an extra
virgin oil (Eu.Ph. 7.0, assay 2.5.1, 2.5.3, 2.5.4), i.e., free acidity, sap-
onification, ester, peroxide, and iodine values.
Reagents and standards
All solvents and reagents were of analytical grade and purchased
from Sigma-Aldrich: n-hexane, anhydrous sodium sulfate, meth-
anol, ethanol, petroleum ether, potassium hydroxide, phenolph-
thalein, chloroform iodide, sodium thiosulfate, starch solution,
Wijs solution (iodine monochloride with glacial acetic acid), and
carbon tetrachloride. Gaseous hydrochloric acid (HClg) was from
Sapio. Analytical standards α-tocopherol (Eu.Ph. grade), α-amyr-
in (HPLC purity > 98.5%), β-amyrin (HPLC purity > 98%), squalene
(HPLC purity > 98%), lanosterol (purity > 93%), stigmasterol (pu-
rity > 95%), cholesta-4,6-dien-3-one (HPLC purity > 98%), β-sito-
sterol (HPLC purity > 97%), and cholesterol (Sigma grade purity
> 99%) were purchased from Sigma-Aldrich. Cycloartanol acetate
(HPLC purity > 90%) was purchased from Extrasynthese. Obtusi-
foliol (HPLC purity > 99%) was from Gamay Industrial Technology
Co. and stigmastan-3–5-diene (HPLC purity > 98%) was fromGelmini F et al. Unsaponifiable Fraction of… Planta Med 2016; 82: 273–278Apollo Scientific, Inc. Gravimetric determination was done using
a precision balance from GIBERTINI® (E50 S model). Grade B (re-
fined) shea butter and beeswax were from I.R.A. and essential
oils were from Aroma-zone.
Sample preparation and unsaponifiable
fraction extraction
The fruits samples (5.00 ± 0.10 g), collected at the different weeks
of maturation, were submitted to a grinding procedure and the
homogenate was extracted under vigorous stirring (T = 1 h) three
times at room temperature with 25mL of n-hexane. The organic
fractions, dried over anhydrous sodium sulphate (10% w/v), were
collected and taken to dryness under vacuum. The oil fraction ob-
tained was submitted to the saponification procedure as de-
scribed [18]. Briefly, the oil sample was saponified under reflux
with 50mL of H2O saturated with KOH (t = 4 h). The UF was ex-
tracted with 100mL of n-hexane (n = 3) and the organic phases
were collected and taken to dryness under vacuum, and the UF
yield was gravimetrically determined. The UFs from oils at differ-
ent stages of maturation were submitted to GC‑MS analysis to
profile the bioactive constituents.
Gas chromatography-mass spectrometry analysis
The UFs from the oils of olives at different stages of maturation
were analyzed by GC‑MS using a Bruker Scion SQ instrument
equipped with a Factor Four capillary column (VF-5 ms, 30m;
0.25mm i.d., film thickness 0.25 µm) coupled with a single-
quadrupole (SQ) detector. The oven temperature was initially set
at 60°C (hold time 3min), with a gradient from 60 to 120°C (8°C/
min, hold 1min), from 120 to 280°C (4°C/min, hold 1min), and
from 280 to 300°C (10°C/min, hold 2.5min); injector tempera-
ture 250°C, hold 95min, column flow 1mL/min. The carrier gas
was helium 5.5, ionization energy 70 eV, and the split/splitless ra-
tio was set at 1:30 after 45 s. Twenty mg of the UF samples were
derivatized with 450 µL of MeOH saturated with gaseous HCl and
left to react for 40min at 42°C. The mixture was then exhaus-
tively extracted with 600 µL of n-hexane (n = 3), and 1 µL of the
extract was analyzed by GC‑FID and characterized by GC‑MS.
Peak identification was performed by retention index analysis
and confirmed by matching their mass spectra with those of the
commercial library NIST mass spectral database (2.0, 2011) or,
when necessary, confirmed with commercial standards. Each
peak was allowed to identify a specific compound and the area
under the peak allowed to semiquantitatively estimate the
amount of this structure. Individual data are expressed as relative
% of the total pool area. In particular, for the GC‑MS quantitative
analysis of triterpenols and sterols, a calibration curve for each
compound was set, and the limit of detection, lower limit of
quantification, and linearity range were evaluated (l" Table 4). In
order to define the recovery of the method for the UF extraction,
500 µg of cholesterol were added to 100 µL of olive oil and sub-
mitted to methylation with 450 µL of MeOH saturated with gas-
eous HCl, as described. The mixture was extracted with 800 µL of
n-hexane, and 1 µL of the organic phase was submitted to GC‑MS
analysis (625 theoretical ng of cholesterol was injected). The ob-
tained peak area was compared with the area from the same
quantity of cholesterol diluted in n-hexane (625 ng/µL). The
mean % of extraction recovery was 98.22 ± 2.73 (n = 3).
Table 4 GC‑MS quantitative analysis of triterpenols and sterols.
Unsaponifiable compound LOD (ng) LLOQ (ng) Linearity range (ng) R2
Squalene 25.7 42.9 42.9–858 0.997
β-Sitosterol 30.7 51.2 51.25–820 0.999
α-Amyrin 21 35 35–350 0.992
α-Tocopherol 22.0 36.7 36.7–7340 0.993
β-Amyrin 21 35 35–350 0.994
Lanosterol 37.2 62 62–2480 0.991
Stigmasterol 34.8 58 58–5800 0.991
Cycloartanol acetate 18 30 30–1650 0.991
Stigmastan-3,5-diene 19.2 32 32–3200 0.994
Obtusifoliol 27 45 45–4500 0.994
Cholesta-4,6-dien-3-one 20.4 34 34–850 0.999
9,19-Ciclolanost-7-en-3-ol 14.4 24 24–820 0.997
Cholest-4-en-3-one 16.8 28 28–560 0.997
Cholesterol extraction recovery 625 ng inj std area 625 ng inj extr area Recovery % Mean SD
190800000 189000000 99.1 98.2 2.73
200800000 191100000 95.2
180650000 181420000 100.4
Fig. 2 GC‑MS analysis of the ointment vehicle. A representative GC‑MS
chromatogram shows the ointment vehicle constituents, which are mainly
fatty acids and paraffins (a: eucalyptol; b: γ-terpinene; c: terpinen-4-ol; d:
palmitic acid; e: linoleic acid; f: oleic acid; g: stearic acid; h: n-tetracosane;
i: arachidic acid; j: n-heptacosane; k: docosanoic acid; l: n-hentriacontane;


































l.Statistical analysis of the analytical data
All of the analyses were carried out in triplicate. The results are
expressed as mean values and standard deviation (SD), and were
analyzed using one-way analysis of variance (ANOVA), followed
by Tukeyʼs HSD test (SPSS v 16.0 program).
Ointment preparation
The ointment contained, as the active component, UF (5% w/w)
from the oil of unripe olives (22 WAF). The vehicle was consti-
tuted by extra virgin olive oil (54%), beeswax (32%), grade B (i.e.,
refined and thus not containing unsaponifiable structures) shea
butter (14%), perfumes (essential oils of mint 0.80% and lavender
0.60%), and preservatives (essential oils of rosemary 0.40% and
tea tree 0.20%, also added as a skin enhancer). The GC‑MS analy-
sis of this vehicle (l" Fig. 2) showed a predominance of fatty acids
(86.49%) and paraffins (12.18%), followed by small amounts of
terpenes (0.98%). To the best of our knowledge, none of these
structures has been shown to exhibit anti-inflammatory activity
in humans. The ointment was examined by routine cosmetic
tests for physical and chemical stability, kindly run by the Istituto
di Ricerche Applicate.
Pilot clinical study
Five outpatient volunteers (twomen and threewomen, mean age
60.2 ± 8.1 years) with symptomatic (hand joints/knees pain) OA
diagnosed 2–5 years prior participated in the study, which was
conducted in accordance with the guidelines of the Declaration
of Helsinki, and the study protocol was approved by the Institu-
tional Ethics Committee (date of approval: July 27, 2012; appro-
val number: 296_07/2012). Written informed consent was ob-
tained from each subject. They were asked to avoid any pharma-
cological treatment starting from three weeks before the begin-
ning of the study (run-in period) and during the three weeks of
the topical application of the UF ointment. Volunteers were in-
structed on a self-application of 5 g/application (three times/dai-
ly) of the ointment on the painful joints of the knees and hands
until complete absorption. It was recommended they keep
strictly to their usual eating habits and avoid any functional foods
that might influence the inflammatory joint disease. All the vol-
unteers were examined by the same physician at the beginning of
the study and at weekly intervals until completion of the treat-ment protocol. The effects of UF on joint pain were assessed
weekly using the visual analogue scale [20]. The signs and symp-
toms of inflammation (joint redness, heat, tissue swelling, loss of
mobility, and joint deformity) were recorded by visual inspection
and physical examination by a physician. The remission of objec-
tive symptoms was expressed using an arbitrary numerical scale
from 0 (best) to 4 (worst). All the volunteers completed the studyGelmini F et al. Unsaponifiable Fraction of… Planta Med 2016; 82: 273–278
278 Original Papersand none experienced any skin irritation or cutaneous allergic re-
actions after application of the UF ointment.
Statistical analysis of the pilot clinical outcomes
The effect of UF ointment treatment on different variables was
assessed by one-way ANOVA for repeated measures. Normality
was assessed by the Kolmogorov-Smirnov test. Continuous vari-
ables are indicated as mean ± SD. Significant differences were
considered when p value ≤ 0.05. Statistical analysis was per-
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